Beam Therapeutics Inc

BEAM NASDAQ Healthcare & Biotech United States US07373V1052
20.94 $
8.28 %

Beam Therapeutics Inc is engaged in the development of genetic therapies targeting genetic mutation diseases using CRISPR technology.